Table 4.
Clone | FP′1 (93) | FP′2 (91) | |
---|---|---|---|
ENPVVHFFRNIVTPR* | ENPVVHFFRNIVTPR | ||
Ho.A226 | R | ⇒ | F |
K | ⇒ | Y,L,H | |
K | ⇐ | Y | |
R | ⇐ | F | |
ENPVVHFFKNIVTPR† | ENPVVHFFKNIVTPR | ||
Hy.152 | K | ⇒ | F |
R | ⇒ | Y,H,A | |
K | ⇐ | F | |
R,L | ⇐ | Y | |
3Ob.1 | K | ⇒ | F |
R | ⇒ | Y,L,H,A | |
K | ⇐ | F | |
H,R | ⇐ | Y |
The table summarizes the allowable amino acid residues that are able to activate T-cell clones >30% of the original stimulating peptide. The arrows point to which amino acids are allowed in one FP given the corresponding amino acid in the other FP.
Ho.A226 was generated against MBPp85-99 (93R) peptide (HFFR).
Hy.152 and 3Ob.1 were generated against MBPp85-99 peptide (HFFK), the native sequence of MBP.